Yi Tan

11.1k citations

190 papers · 9.0k · 2 hit papers · h-index 54

Impact in

Geriatrics and Gerontology top 1%
Clinical Biochemistry top 0.5%

Papers in

Molecular Biology 107
- Fibroblast Growth Factor Research 25
- Genomics, phytochemicals, and oxidative stress 18
- Kruppel-like factors research 15
- Epigenetics and DNA Methylation 12
- Circular RNAs in diseases 12
- Angiogenesis and VEGF in Cancer 11
Nutrition and Dietetics 27
- Trace Elements in Health 25

Co-authors: Lu Cai (113 shared papers)Xiaokun Li (36 shared papers)Kupper A. Wintergerst (20 shared papers)Bradley B. Keller (7 shared papers)Yuehui Wang (22 shared papers)Chi Zhang (24 shared papers)Zhiguo Zhang (3 shared papers)Shanshan Zhou (20 shared papers)
Journals: Journal of Cellular and Molecular Medicine (14 papers)Oxidative Medicine and Cellular Longevity (12 papers)Toxicology Letters (10 papers)Diabetes (8 papers)PLoS ONE (7 papers)
Partner nations: China United States Thailand

In The Last Decade

Yi Tan

184 papers receiving 8.9k citations

Yi Tan's Hit Papers

align trajectories log scale

Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways 2021 · 394 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Acta Pharmaceutica Sinica B
2020 Nature Reviews Cardiology

Peers

Countries citing papers authored by Yi Tan

Since Specialization

Citations

This map shows the geographic impact of Yi Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Tan more than expected).

Fields of papers citing papers by Yi Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Tan. The network helps show where Yi Tan may publish in the future.

Co-authors

The 25 scholars most cited alongside Yi Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yi Tan Line = papers co-authored together Yi Tan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 190 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence Nature Reviews Cardiology ·Yi Tan, Zhiguo Zhang, Chao Zheng, Kupper A. Wintergerst, Bradley B. Keller, Lu Cai Hit paper breakdown →	2020	573
2	Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways Acta Pharmaceutica Sinica B ·Xiang Wang, Xinxin Chen, Wenqian Zhou, Hongbo Men, Terigen Bao, Yike Sun, Quanwei Wang, Yi Tan, Bradley B. Keller, Qian Tong, Yang Zheng, Lu Cai Hit paper breakdown →	2021	394
3	Diabetic Downregulation of Nrf2 Activity via ERK Contributes to Oxidative Stress–Induced Insulin Resistance in Cardiac Cells In Vitro and In Vivo Diabetes ·Yi Tan, Tomonaga Ichikawa, Jinqing Li, Qiusheng Si, Huaitao Yang, Xiangbai Chen, Curtis Goldblatt, Colin J. Meyer, Xiaokun Li, Lu Cai, Taixing Cui	2011	342
4	Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation Journal of Molecular and Cellular Cardiology ·Yang Bai, Wenpeng Cui, Ying Xin, Xiao Miao, Michelle T. Barati, Chi Zhang, Qiang Chen, Yi Tan, Taixing Cui, Yang Zheng, Lu Cai	2013	239
5	Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy Diabetes ·Junlian Gu, Yanli Cheng, Hao Wu, Lili Kong, Shudong Wang, Zheng Xu, Zhiguo Zhang, Yi Tan, Bradley B. Keller, Honglan Zhou, Yuehui Wang, Zhonggao Xu, Lu Cai	2016	169
6	Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway Journal of Molecular and Cellular Cardiology ·Zhiguo Zhang, Shudong Wang, Shanshan Zhou, Xiaoqing Yan, Yonggang Wang, Jing Chen, Nicholas Mellen, Maiying Kong, Junlian Gu, Yi Tan, Yang Zheng, Lu Cai	2014	168
7	Exacerbation of diabetes-induced testicular apoptosis by zinc deficiency is most likely associated with oxidative stress, p38 MAPK activation, and p53 activation in mice Toxicology Letters ·Yuguang Zhao, Yi Tan, Dai Junying, Bing Li, Luping Guo, Jiuwei Cui, Guanjun Wang, Xue Shi, Xiang Zhang, Nicholas Mellen, Wei Li, Lu Cai	2010	167
8	Nrf2: Redox and Metabolic Regulator of Stem Cell State and Function Trends in Molecular Medicine ·Xiaozhen Dai, Xiaoqing Yan, Kupper A. Wintergerst, Lu Cai, Bradley B. Keller, Yi Tan	2019	164
9	Inactivation of GSK-3β by Metallothionein Prevents Diabetes-Related Changes in Cardiac Energy Metabolism, Inflammation, Nitrosative Damage, and Remodeling Diabetes ·Yuehui Wang, Wenke Feng, Wanli Xue, Yi Tan, David W. Hein, Xiaokun Li, Lu Cai	2009	149
10	Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ß/Fyn pathway Redox Biology ·Ying Xin, Yang Bai, Xin Jiang, Shanshan Zhou, Yuehui Wang, Kupper A. Wintergerst, Taixing Cui, Honglei Ji, Yi Tan, Lu Cai	2018	146
11	Oxidative Stress, Diabetes, and Diabetic Complications Hemoglobin ·Wei Wei, Qiuju Liu, Yi Tan, (unknown), Xiaokun Li, Lu Cai	2009	142
12	Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice Clinical Science ·Jingjing Zhang, Yanli Cheng, Junlian Gu, Shudong Wang, Shanshan Zhou, Yuehui Wang, Yi Tan, Wenke Feng, Yaowen Fu, Nicholas Mellen, Rui Cheng, Jian‐xing Ma, Chi Zhang, Zhanquan Li, Lu Cai	2016	140
13	Acceleration of diabetic wound healing with chitosan-crosslinked collagen sponge containing recombinant human acidic fibroblast growth factor in healing-impaired STZ diabetic rats Life Sciences ·Wei Wang, Shaoqiang Lin, Yechen Xiao, Yadong Huang, Yi Tan, Lu Cai, Xiaokun Li	2007	129
14	Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism Kidney International ·Guang Liang, Lintao Song, Zilu Chen, Yuanyuan Qian, Jun-Jun Xie, Longwei Zhao, Qian Lin, Guanghui Zhu, Yi Tan, Xiaokun Li, Moosa Mohammadi, Zhifeng Huang	2017	126
15	Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21 British Journal of Pharmacology ·Yixuan Sun, Mingfeng Xia, Hongmei Yan, Yamei Han, Feifei Zhang, Zhimin Hu, Aoyuan Cui, Fengguang Ma, Zhengshuai Liu, Qiyong Gong, Xüqing Chen, Jing Gao, Hua Bian, Yi Tan, Yu Li, Xin Gao	2017	125
16	Cadmium and Its Epigenetic Effects Current Medicinal Chemistry ·B. Wang, Y. Li, (unknown), Yi Tan, Lu Cai	2012	123
17	Elevating CXCR7 Improves Angiogenic Function of EPCs via Akt/GSK-3β/Fyn-Mediated Nrf2 Activation in Diabetic Limb Ischemia Circulation Research ·Xiaozhen Dai, Xiaoqing Yan, Jun Zeng, Jing Chen, Yuehui Wang, Jun Chen, Yan Li, Michelle T. Barati, Kupper A. Wintergerst, Kejian Pan, Matthew A. Nystoriak, Daniel J. Conklin, Gregg Rokosh, Paul N. Epstein, Xiaokun Li, Yi Tan	2017	122
18	Prevention of Diabetic Nephropathy by Sulforaphane: Possible Role of Nrf2 Upregulation and Activation Oxidative Medicine and Cellular Longevity ·Wenpeng Cui, Yang Bai, Xiao Miao, Ping Luo, Qiang Chen, Yi Tan, Madhavi J. Rane, Lining Miao, Lu Cai	2012	122
19	Role of Iron Deficiency and Overload in the Pathogenesis of Diabetes and Diabetic Complications Current Medicinal Chemistry ·Qiuju Liu, Liang Sun, Yi Tan, Guanjun Wang, Xu Lin, Lu Cai	2008	118
20	Interplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy American Journal of Physiology-Renal Physiology ·Madhavi J. Rane, Ye Song, Shunying Jin, Michelle T. Barati, Rui Wu, Hina Kausar, Yi Tan, Yuehui Wang, Guihua Zhou, Jon B. Klein, Xiaokun Li, Lu Cai	2009	114

About Yi Tan

Yi Tan is a scholar working on Molecular Biology, Nutrition and Dietetics, Cardiology and Cardiovascular Medicine, Cancer Research and Oncology, having authored 190 papers that have together received 9.0k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (25 papers), Trace Elements in Health (25 papers), Genomics, phytochemicals, and oxidative stress (18 papers), Kruppel-like factors research (15 papers), Cardiovascular Function and Risk Factors (13 papers), Epigenetics and DNA Methylation (12 papers), Circular RNAs in diseases (12 papers) and Angiogenesis and VEGF in Cancer (11 papers). The work is most often cited by research in Geriatrics and Gerontology (221 citations), Clinical Biochemistry (402 citations), Molecular Biology (4.2k citations), Nutrition and Dietetics (881 citations) and Cardiology and Cardiovascular Medicine (1.2k citations). Yi Tan has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Lu Cai, Xiaokun Li, Kupper A. Wintergerst, Bradley B. Keller, Yuehui Wang, Chi Zhang, Zhiguo Zhang, Shanshan Zhou, Xiaoqing Yan and Chao Zheng. Their work appears in journals such as Journal of Cellular and Molecular Medicine, Oxidative Medicine and Cellular Longevity, Toxicology Letters, Diabetes and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Yi Tan

Impact in

Papers in i

In The Last Decade

Yi Tan

Yi Tan's Hit Papers

Peers

Countries citing papers authored by Yi Tan

Fields of papers citing papers by Yi Tan

All Works

About Yi Tan

Explore authors with similar magnitude of impact

Papers in